首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   219716篇
  免费   12082篇
  国内免费   6434篇
耳鼻咽喉   2749篇
儿科学   8258篇
妇产科学   2983篇
基础医学   16777篇
口腔科学   4173篇
临床医学   26710篇
内科学   39703篇
皮肤病学   3023篇
神经病学   10841篇
特种医学   12144篇
外国民族医学   22篇
外科学   32872篇
综合类   19477篇
现状与发展   25篇
预防医学   14653篇
眼科学   4403篇
药学   23818篇
  80篇
中国医学   4488篇
肿瘤学   11033篇
  2023年   1873篇
  2022年   3656篇
  2021年   8885篇
  2020年   5158篇
  2019年   11088篇
  2018年   5708篇
  2017年   4891篇
  2016年   6889篇
  2015年   9729篇
  2014年   17789篇
  2013年   15509篇
  2012年   18825篇
  2011年   15603篇
  2010年   14399篇
  2009年   14015篇
  2008年   12593篇
  2007年   12671篇
  2006年   10666篇
  2005年   7009篇
  2004年   3484篇
  2003年   3057篇
  2002年   2476篇
  2001年   1951篇
  2000年   1770篇
  1999年   1094篇
  1998年   1485篇
  1997年   1355篇
  1996年   1143篇
  1995年   1216篇
  1994年   1174篇
  1993年   913篇
  1992年   1127篇
  1991年   1028篇
  1990年   1052篇
  1989年   1029篇
  1988年   949篇
  1987年   833篇
  1986年   678篇
  1985年   1594篇
  1984年   1748篇
  1983年   1259篇
  1982年   1349篇
  1981年   1333篇
  1980年   1151篇
  1979年   987篇
  1978年   763篇
  1977年   759篇
  1976年   662篇
  1975年   437篇
  1974年   457篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
《Drug discovery today》2022,27(1):223-233
Approaches based on animal and two-dimensional (2D) cell culture models cannot ensure reliable results in modeling novel pathogens or in drug testing in the short term; therefore, there is rising interest in platforms such as organoids. To develop a toolbox that can be used successfully to overcome current issues in modeling various infections, it is essential to provide a framework of recent achievements in applying organoids. Organoids have been used to study viruses, bacteria, and protists that cause, for example, respiratory, gastrointestinal, and liver diseases. Their future as models of infection will be associated with improvements in system complexity, including abilities to model tissue structure, a dynamic microenvironment, and coinfection.Teaser.Organoids are a flexible tool for modelling viral, bacterial and protist infections. They can provide fast and reliable information on the biology of pathogens and in drug screening, and thus have become essential in combatting emerging infectious diseases.  相似文献   
52.
Ochratoxin A (OTA) is a mycotoxin that mainly causes nephrotoxicity. The single nephrotoxicity of OTA exposure on glomeruli or renal tubule had been well documented, however, the comparison toxicity between it is still unclear. Here, C57BL/6 mice and two types of nephrocyte were treated with concentration-gradient OTA to explore its differentiation nephrotoxicity. Results showed that OTA induced nephrotoxicity in vivo and in vitro, manifested as the deteriorative kidney function in mice and the cut-down cell viability in nephrocyte. Besides, results of murine kidney pathological section and IC50 of two types nephrocyte indicated that OTA-induced toxicity in renal tubule was higher than its in glomeruli. In addition, OTA exposure induced autophagy signaling differentiation expression. It revealed that autophagy was implicated in OTA-induced differential nephrotoxicity in glomeruli and renal tubule. Altogether, we proved that OTA induces a differentiation nephrotoxicity in glomeruli and renal tubule, and it is related to autophagy differential regulation.  相似文献   
53.
54.
垂体腺瘤(PA)通常引起性腺轴的损害,导致女性患者的生育能力下降。妊娠可使垂体增大,而性腺轴的激素分泌也随之发生相应改变。因此,对患有PA的妊娠妇女的规范化管理显得尤为重要。2021年8月,欧洲内分泌学会(ESE)发布了关于妊娠期功能性和无功能性PA的临床指南,该指南从腺瘤的大小、位置和有无内分泌功能方面,描述了从妊娠前到分娩后诊断、治疗的时机和选择。本文在ESE指南的基础上,对该指南进行了解读,总结了该指南的要点,以期结合中国的临床经验及患者特点,为临床医师管理此类患者提供具有实践意义的指导意见。  相似文献   
55.
56.
57.
IntroductionThe Knowledge of Genome Sequencing (KOGS) questionnaire was recently developed to measure knowledge of genomic sequencing (GS), with preliminary psychometric data supporting its reliability and validity. The aim of this study was to test the reliability and validity of the KOGS in a larger sample, and to confirm its utility in a cancer setting.MethodsThe Genetic Cancer Risk in the Young (RisC) study recruits participants with a personal history of cancer, to investigate heritable cancer causes and future cancer risk using germline GS. Participants (n = 261) in a psychosocial substudy of RisC completed a questionnaire after consent to RisC but before GS, including the KOGS, the Intolerance of Uncertainty Scale, the Chew health literacy scale and items assessing demographic and disease variables. Confirmatory factor analysis (CFA), Cronbach alpha and correlational analyses were undertaken.ResultsThe CFA testing a single-factor model yielded a good model fit, χ2/df = 2.43, comparative fit index (CFI) = 0.97, root mean square error of approximation (RMSEA) = 0.07 and weighted mean root square (WRMR) = 1.03. Factor loadings of all items were above 0.60 and ranged between.66 and.93. The single factor score demonstrated excellent internal consistency (α = 0.82). KOGS scores were significantly associated with health literacy (r = 0.23, p < .001), having a university education [t(258) = ?4.53, p < .001] and having a medical or science background [t(259) = ?3.52, p < .001] but not with speaking a language other than English at home, time since diagnosis, previous genetic counselling/testing or intolerance of uncertainty.DiscussionThis study confirmed a single-factor structure for the KOGS, and its reliability and validity in a cancer population. Associations with measures of health literacy and education were significant and positive as expected, supporting the KOG’s construct validity. Previous genetic counselling may not be sufficient to provide specific knowledge of GS.  相似文献   
58.
59.
《Drug discovery today》2022,27(1):246-256
Bromodomain-containing protein 4 (BRD4) is emerging as a therapeutic target that acts synergistically with other targets of small-molecule drugs in cancer. Therefore, the discovery of potential new dual-target inhibitors of BRD4 may be a promising strategy for cancer therapy. In this review, we highlight a series of strategies to design therapeutic dual-target inhibitors of BRD4 that focus on the synergistic functions of this protein. Drug combinations that exploit synthetic lethality, protein–protein interactions, functional complementarity, and blocking of resistance mechanisms could ultimately overcome the barriers inherent to the development of BRD4 inhibitors as future cancer drugs.  相似文献   
60.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号